Request Legal Help Now - Free
LAWSUITS NEWS & LEGAL INFORMATION
Home Page >> Legal News Articles >> Defective Products

Legal News Articles - Defective Products

Zetia and Vytorin Continue to be Controversial

Zetia and Vytorin Continue to be Controversial August 28, 2017. By Gordon Gibb.
Washington, DC: There is little doubt that the cholesterol-fighting drug Zetia (ezetimibe) has travelled a rocky road since it was first approved by the US Food and Drug Administration (FDA) in 2002. And while several years have passed since the controversial delay in releasing study results into potential Zetia side effects, issues involving Zetia and its cousin Vytorin (Zetia in combination with a statin) continue to lazily percolate like water at a gentle boil.
Read [ Zetia and Vytorin Continue to be Controversial ]

Signs of Movement in the Taxotere Litigation Process

Signs of Movement in the Taxotere Litigation Process August 27, 2017. By Brenda Craig.
Dallas, TX Allegations that hundreds of American women experienced permanent hair loss as a result of using the breast cancer treatment drug Taxotere (Docetaxel) are about to be tested in court in a bellwether trial slated for next fall.
Read [ Signs of Movement in the Taxotere Litigation Process ]

Stryker Hip Replacement Leads to more Broken Bones

Stryker Hip Replacement Leads to more Broken Bones August 27, 2017. By Jane Mundy.
Kansas City, MO: Since Karen’s hip replacement two years ago, she has broken her foot, a toe and a tooth. She blames the broken bones on her Stryker hip implant and not being able to walk correctly.
Read [ Stryker Hip Replacement Leads to more Broken Bones ]

Still Too Soon to Take Echeverria to the Bank

Still Too Soon to Take Echeverria to the Bank August 26, 2017. By Anne Wallace.
Los Angeles, CA: The plaintiffs’ bar is literally agog at the $417 million awarded by a Los Angeles jury to a woman who developed ovarian cancer after using Johnson’s Baby Powder for decades. The Johnson & Johnson lawsuit is the first talcum powder lawsuit to go to trial in California. Plaintiffs should certainly feel heartened at the outcome, but there are three major hurdles to be faced in the cases that follow.
Read [ Still Too Soon to Take Echeverria to the Bank ]

Insulation Failure, Battery Failure and Cyber Hacking - A Triple Threat for Pacemaker Patients

Insulation Failure, Battery Failure and Cyber Hacking - A Triple Threat for Pacemaker Patients August 24, 2017. By Anne Wallace.
Washington, DC: Premature insulation failure in recalled St. Jude Medical Riata defibrillator (ICD) leads may be only the tip of the iceberg for heart patients with ICDs, more commonly known as “pacemakers.”
Read [ Insulation Failure, Battery Failure and Cyber Hacking - A Triple Threat for Pacemaker Patients ]

Philadelphia Judge Refuses to Overturn $2.5 Million Risperdal Plaintiff Verdict

Philadelphia Judge Refuses to Overturn $2.5 Million Risperdal Plaintiff Verdict August 23, 2017. By Gordon Gibb.
Philadelphia, PA: If there was ever any doubt that Risperdal gynecomastia was a compelling issue that too few knew about, that myth was dispelled when a Risperdal lawsuit landed squarely onto the pages of People Magazine in February, 2015.
Read [ Philadelphia Judge Refuses to Overturn $2.5 Million Risperdal Plaintiff Verdict ]

Replacement Airbags Pose Serious Risk of Injury to Consumers

Replacement Airbags Pose Serious Risk of Injury to Consumers August 23, 2017. By Anne Wallace.
Las Vegas, NV: On Friday, August 18, 2017, attorneys for Karina Dorado, a young woman who suffered severe airbag injuries, filed suit in a Nevada state court. The case highlights the danger consumers face from replacement airbags. These are situations that slip through the cracks of massive airbag recall efforts and remain largely unaddressed by law.
Read [ Replacement Airbags Pose Serious Risk of Injury to Consumers ]

Janumet Patient Felled by Cancer of the Pancreas in 2012

Janumet Patient Felled by Cancer of the Pancreas in 2012 August 22, 2017. By Gordon Gibb.
Los Angeles, CA: When Janumet (sitagliptin and metformin combined) was approved by the US Food and Drug Administration (FDA) in 2007, the type 2 diabetes drug was within five years of achieving sales of $1.7 Billion. That year, when Janumet hit blockbuster status by 2012, the parent drug of Janumet – Januvia – earned $4 Billion for manufacturer Merck & Co. Januvia has been associated with Januvia side effects, and has resulted in Januvia cancer lawsuits.
Read [ Janumet Patient Felled by Cancer of the Pancreas in 2012 ]

Heart Surgery Patient Blames Stockert 3T Heater-Cooler System for Infections

Heart Surgery Patient Blames Stockert 3T Heater-Cooler System for Infections August 22, 2017. By Jane Mundy.
Toronto, ON:Four years ago David had triple bypass heart surgery and he has been suffering from infections ever since. “Nobody could tell us why he was getting so many infections, until we got a letter from the hospital that said this Stockert 3T heater-cooler system used during surgery is linked to a rare bacterial infection,” says Shelly, David’s wife.
Read [ Heart Surgery Patient Blames Stockert 3T Heater-Cooler System for Infections ]

The Human Body is Designed to Move, Whereas the IVC Filter is Not: A Disconnect?

The Human Body is Designed to Move, Whereas the IVC Filter is Not: A Disconnect? August 21, 2017. By Gordon Gibb.
Washington, DC: The idea behind the IVC filter may have been meritorious: for those patients at high risk for blood clot or pulmonary embolism, for whom blood thinners are either not appropriate or ineffective, a so-called ‘catcher’s mitt’ strategically placed within the inferior vena cava artery will entrap a blood clot migrating up from the lower extremities, preventing the clot from reaching the heart or lungs.
Read [ The Human Body is Designed to Move, Whereas the IVC Filter is Not: A Disconnect? ]

Page: 1  2  3  4  5  6  7  8  9  -  10»  -  43   Next»
Request Legal Help Now! - Free